Add Formweb to your mobile device
Search results for:
eculizumab
eculizumab
Brand names: Soliris
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, INTRAVENOUS | 10 mg/mL | Restricted |
Last updated: Dec. 17, 2024
- Black Box Warning: Meningococcal Infection
- REMS: View FDA REMS info
- Restricted: Soliris is formulary restricted to outpatient use (not preferred) and inpatient use for atypical hemolytic uremic syndrome only.
**Please ensure patient and provider is enrolled in REMS program SOLIRIS REMS and has received appropriate vaccines**